Kringle Pharma,Inc. Stock: price and insider trades · Japan

Kringle Pharma,Inc., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to EDINET (Japan FSA). The last twelve months, up to 18 October 2026, brought 9 filings signed by 1 insider.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

For context, the typical company on the same exchange (median of 3,427 companies) published 3 filings over the same period, against 9 filings here.

There has been no open-market purchase by an insider of Kringle Pharma,Inc. for at least a year. Typically, a trade is published a median of 7 days after it takes place. The shorter that gap, the sooner other investors can see what insiders have done.

Elsewhere in the same sector, our signals recently picked up insider purchases at Cooper Companies, Inc. and Cytosorbents Corp. These figures are compiled from regulatory filings published by EDINET (Japan FSA). They describe what insiders did and are not a recommendation.